Stoke Therapeutics (STOK) Receivables - Other (2018 - 2026)

Stoke Therapeutics' Receivables - Other history runs 9 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 178.88% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 178.88% YoY), while the FY2025 annual figure was $2.0 million, up 181.29% from the prior year.
• Receivables - Other for Q1 2026 stood at $1.7 million, down from $2.0 million in the prior quarter.
• The five-year high for Receivables - Other was $2.0 million in Q4 2025, with the low at $11000.0 in Q1 2024.
• The 5-year median for Receivables - Other is $492000.0 (2023), against an average of $680529.4.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other tumbled 97.76% in 2024, then jumped 5409.09% in 2025.
• Stoke Therapeutics' Receivables - Other stood at $588000.0 in 2022, then tumbled by 89.12% to $64000.0 in 2023, then jumped by 993.75% to $700000.0 in 2024, then surged by 181.29% to $2.0 million in 2025, then decreased by 14.17% to $1.7 million in 2026.
• Business Quant data shows STOK's Receivables - Other at $1.7 million in Q1 2026, $2.0 million in Q4 2025, and $1.6 million in Q3 2025.